New mechanisms involved in the pathogenesis of pituitary adenomas.

被引:0
|
作者
Giacomini, D
Paez-Pereda, M
Refojo, D
Nagashima, AC
Chervin, A
Goldberg, V
Arzt, E
机构
[1] Univ Buenos Aires, Dept Fisiol & Biol Celular & Mol, FCEN, RA-1428 Buenos Aires, DF, Argentina
[2] Hosp Santa Lucia, Buenos Aires, DF, Argentina
[3] Univ Buenos Aires, Fac Med, Inst Invest Med Alfredo Lanari, RA-1428 Buenos Aires, DF, Argentina
关键词
prolactinoma; c-Myc;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
New mechanisms involved in the pathogenesis of pituitary adenomas. We studied Smad-4dn tumors generated from lactosomatotrophic GH3 cells stably transfected with a dominant negative form of Smad-4 (a bone morphogenetic protein-4, BMP-4, signal co-transducer) which had reduced tumorigenicity in nude mice, but had showed a late increase in tumor size. We found that they had lost in vivo the expression of Smad-4dn and had recovered c-Myc expression. In accordance, BMP-4 is overexpressed and stimulates the expression of c-Myc in human prolactinomas, but not in other human pituitary adenomas or normal pituitary. In adittion ICI 182,780 inhibited BMP-4 stimulated c-Myc expression and BMP-4 and 17beta-estradiol in combination had an additive effect on GH3 cell proliferation. Their action was inhibited by blocking BMP-4 with ICI 182,780 or 117beta-estradiol with Smad-4dn. Furthermore, co-immunoprecipitation studies demonstrate that Smad-4 physically interacts with the ERalpha/ERbeta. We show for the first time the role of BMP-4 in prolactinoma pathogenesis, involving a functional cross-talk BMP-4/E2.
引用
收藏
页码:147 / 150
页数:4
相关论文
共 50 条
  • [21] The cytogenesis and pathogenesis of pituitary adenomas
    Asa, SL
    Ezzat, S
    ENDOCRINE REVIEWS, 1998, 19 (06) : 798 - 827
  • [22] PITUITARY ADENOMAS. SURGICAL MANAGEMENT OF 16 PATIENTS IN YAOUNDE CAMEROON
    Eloundou Ngah, Joseph
    Eyenga, Victor Claude
    Ngowe Ngowe, Marcellin
    Atangana, Rene
    Sosso, Maurice Aurelien
    AFRICAN JOURNAL OF NEUROLOGICAL SCIENCES, 2009, 28 (02): : 55 - 60
  • [23] Molecular pathogenesis of pituitary adenomas
    Mennel, HD
    STRAHLENTHERAPIE UND ONKOLOGIE, 2001, 177 (07) : 373 - 374
  • [24] THE PATHOGENESIS OF PITUITARY-ADENOMAS
    MORANGERAMOS, I
    PELLEGRINI, I
    CACCAVELLI, L
    BRUE, T
    ENJALBERT, A
    JAQUET, P
    ANNALES D ENDOCRINOLOGIE, 1994, 55 (01) : 25 - 32
  • [25] PITUITARY-ADENOMAS - PATHOGENESIS
    EZRIN, C
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1984, 36 (02): : 205 - 206
  • [26] THE PATHOGENESIS OF PITUITARY-ADENOMAS
    LEVY, A
    LIGHTMAN, SL
    CLINICAL ENDOCRINOLOGY, 1993, 38 (06) : 559 - 570
  • [27] FOXO1 Expression Is Reduced in Human Pituitary Adenomas.
    Farris, C. L.
    Jung, D. O.
    Lloyd, R. V.
    Ellsworth, B. S.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [28] Stereotactic radiosurgery and fractionated stereotactic radiotherapy for management of pituitary adenomas.
    Tseng, L
    DeSalles, A
    Frighetto, L
    Selch, M
    Cabatan-Awang, C
    Ford, J
    Solberg, T
    JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 : S181 - S181
  • [29] Glucocorticoid receptor expression in nontumorous human pituitaries and pituitary adenomas.
    Rotondo, F
    Kovacs, K
    Stefaneanu, L
    Lloyd, RV
    Scheithauer, BW
    FASEB JOURNAL, 2000, 14 (04): : A570 - A570
  • [30] Stem Cell Markers Gene Expression in Corticotroph Pituitary Adenomas.
    Araujo, Ricardo V.
    Soares, Ibere C.
    Fragoso, Maria Candida B. V.
    Bronstein, Marcello D.
    Mendonca, Berenice B.
    Carvalho, Luciani R.
    ENDOCRINE REVIEWS, 2010, 31 (03)